Journal article
The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations
M Bonello, TL Applegate, S Badman, CS Bradshaw, A Broom, P Field, JS Hocking, WM Huston, F Kong, GL Murray, E Mokany, S Pasricha, AV Todd, DM Whiley, V Wiseman, R Guy
Microbiology Australia | CSIRO PUBLISHING | Published : 2024
DOI: 10.1071/MA24017
Open access
Abstract
Antimicrobial resistance (AMR) is recognised as one of the greatest scientific challenges of the 21st century, disproportionately affecting people living in low- and middle-income countries. With bacterial pathogens becoming increasingly resistant to antibiotics, there is an urgent need for innovative approaches to combat this growing threat. The World Health Organization has recognised this need and prioritised further research to enhance diagnostics, surveillance and our understanding the epidemiology and drivers of AMR. The Industrial Transformation Research Hub to Combat AMR, or the AMR Hub, is an Australian collaborative private–public research partnership involving over 20 organisation..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
S. Badman is a paid employee of Cepheid Pty Ltd, USA. E. Mokany and A. V. Todd are paid employees and shareholders of SpeeDx Pty Ltd. This paper was supported by the Australian Research Council Industrial Transformation Research Hub to Combat Antimicrobial Resistance (ARC ITRP; IH190100021). The ARC ITRP grant includes cash support from AMR Hub Partner organisations, SpeeDx Pty Ltd, Cepheid Pty Ltd and GARDP Foundation. D. M. Whiley received investigator-driven research funding from SpeeDx Pty Ltd.